Document is current

Any future updates will be listed below

SOLO2 confirms olaparib maintenance in ovarian cancer

Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.130

Published Online: 2017-08-16

Published Print: 2017-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark